.jpg)
.png)
All
The content you requested is not available. The content either: Requires a valid user account, logged in to the website, or Special permissions, or Does not exist on this system, or Is seasonal or time sensitive content that is no longer relevant or appropriate, or Is currently under... more
Lipoproteins, Lipids, Cognitive Impairment and Vascular Disease Lipid Luminations
Remnant Lipoproteins Promote Foam Cell Formation Atherosclerosis is characterized by accumulation of inflammatory foam cells whose formation is promoted by the subendothelial retention of ApoBcontaining lipoproteins. Plaques develop in predisposed areas of the arterial tree where blood flow is... more
Level 1 / Basic Primary Care Symposia & Self-Assessment Modules Fellows/Student Mentoring, Training & Assessment Programs Outreach Symposia Level 2 / Core NLA Lipid Academy™ NLA Annual... more
A healthy diet is a powerful tool for the prevention and management of cardiovascular disease (CVD).1 Despite low-fat recommendations, the prevalence of obesity continues to increase steadily,2 because fat intake has not decreased in the United States.3 Accompanying this rise is the... more
Amgen announced today that the FOURIER trial met its primary and secondary endpoints in evaluating whether evolocumab reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) without new safety issues. Amgen also announced that the... more
The 2015 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw yet another significant increase — from 3.904 (2014) to 4.906 (2015). The Journal is now ranked 23rd out of 253 journals in its category (pharmacology and pharmacy... more
This issue is sponsored by the Northeast Lipid Association. Featuring: "Evaluation of Women for the Primary Prevention of Atherosclerotic Cardiovascular Disease" "Current Understanding of the Contribution of Lipoprotein(a) to Atherosclerotic CardiovascularDisease Risk in Women" "Conventional... more
A Review of USPSTF Recommendations for Use of Novel Markers in Risk Stratification Risk Stratification of Dyslipidemia in the Pediatric Population